As of 2025-10-19, the Relative Valuation of Novavax Inc (NVAX) is 41.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.10 USD, the upside of Novavax Inc based on Relative Valuation is 409.4%.
The range of the Relative Valuation is 33.84 - 48.99 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 16.5x | 15.8x |
| Forward P/E multiples | 13.0x - 18.8x | 16.0x |
| Fair Price | 33.84 - 48.99 | 41.26 |
| Upside | 317.8% - 504.9% | 409.4% |
| Date | P/E |
| 2025-10-17 | 3.11 |
| 2025-10-16 | 3.26 |
| 2025-10-15 | 3.42 |
| 2025-10-14 | 3.41 |
| 2025-10-13 | 3.31 |
| 2025-10-10 | 3.20 |
| 2025-10-09 | 3.30 |
| 2025-10-08 | 3.42 |
| 2025-10-07 | 3.54 |
| 2025-10-06 | 3.49 |
| 2025-10-03 | 3.63 |
| 2025-10-02 | 3.67 |
| 2025-10-01 | 3.65 |
| 2025-09-30 | 3.33 |
| 2025-09-29 | 3.29 |
| 2025-09-26 | 3.28 |
| 2025-09-25 | 3.20 |
| 2025-09-24 | 3.32 |
| 2025-09-23 | 3.33 |
| 2025-09-22 | 3.41 |
| 2025-09-19 | 3.35 |
| 2025-09-18 | 3.28 |
| 2025-09-17 | 3.22 |
| 2025-09-16 | 3.29 |
| 2025-09-15 | 3.10 |
| 2025-09-12 | 3.07 |
| 2025-09-11 | 3.18 |
| 2025-09-10 | 3.06 |
| 2025-09-09 | 3.06 |
| 2025-09-08 | 2.97 |
| 2025-09-05 | 3.03 |
| 2025-09-04 | 2.99 |
| 2025-09-03 | 2.84 |
| 2025-09-02 | 2.90 |
| 2025-08-29 | 2.87 |
| 2025-08-28 | 2.91 |
| 2025-08-27 | 2.91 |
| 2025-08-26 | 2.88 |
| 2025-08-25 | 2.89 |
| 2025-08-22 | 3.01 |
| 2025-08-21 | 2.93 |
| 2025-08-20 | 3.36 |
| 2025-08-19 | 3.66 |
| 2025-08-18 | 3.73 |
| 2025-08-15 | 3.68 |
| 2025-08-14 | 3.62 |
| 2025-08-13 | 3.40 |
| 2025-08-12 | 3.26 |
| 2025-08-11 | 3.08 |
| 2025-08-08 | 3.22 |